chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy
Clinical narrative: Swelling in lymph node under armpit; under armpit is feeling a bit sore; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swelling in lymph node under armpit) and AXILLARY PAIN (under armpit is feeling a bit sore) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Swelling in lymph node under armpit) and AXILLARY PAIN (under armpit is feeling a bit sore). At the time of the report, LYMPHADENOPATHY (Swelling in lymph node under armpit) and AXILLARY PAIN (under armpit is feeling a bit sore) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-417302 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Chills, Vaccination complication
Clinical narrative: Had some symptoms after the second one; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had some symptoms after the second one) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Had some symptoms after the second one) and CHILLS (Chills). At the time of the report, VACCINATION COMPLICATION (Had some symptoms after the second one) and CHILLS (Chills) outcome was unknown.            Concomitant medication was not reported. Treatment information was not reported.   This case was linked to MOD-2021-417302 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Someone came in for a 2nd dose of the Moderna Covid-19 vaccine. He got booster dose amount of 0.25mL instead.; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Someone came in for a 2nd dose of the Moderna Covid-19 vaccine. He got booster dose amount of 0.25mL instead.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Dec-2021, the patient experienced UNDERDOSE (Someone came in for a 2nd dose of the Moderna Covid-19 vaccine. He got booster dose amount of 0.25mL instead.). On 16-Dec-2021, UNDERDOSE (Someone came in for a 2nd dose of the Moderna Covid-19 vaccine. He got booster dose amount of 0.25mL instead.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: Consumer states his blood work was always abnormal. Since he received the moderna booster dose, his blood work is now normal'; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Consumer states his blood work was always abnormal. Since he received the moderna booster dose, his blood work is now normal') in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A, 017B21A and 939905) for COVID-19 vaccination.     Concurrent medical conditions included CLL (Diagnosed with cancer 5 years ago. He was in remission, without any radiation or chemo treatment.).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Consumer states his blood work was always abnormal. Since he received the moderna booster dose, his blood work is now normal'). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Consumer states his blood work was always abnormal. Since he received the moderna booster dose, his blood work is now normal') outcome was unknown.            Concomitant and treatment medication was not reported.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vomiting
Clinical narrative: Vomiting after 3rd shot; Fever 103 F after 3rd Shot / Fever goes up and down even without Tylenol; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 103 F after 3rd Shot / Fever goes up and down even without Tylenol) and VOMITING (Vomiting after 3rd shot) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069H21A, 029L20A and 042L20A) for COVID-19 vaccination.     The patient's past medical history included Cancer.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever 103 F after 3rd Shot / Fever goes up and down even without Tylenol). On 16-Dec-2021, the patient experienced VOMITING (Vomiting after 3rd shot). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Fever, at an unspecified dose and frequency. On 16-Dec-2021, VOMITING (Vomiting after 3rd shot) had resolved. At the time of the report, PYREXIA (Fever 103 F after 3rd Shot / Fever goes up and down even without Tylenol) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Dec-2021, Body temperature: 103 (High) 103 Fahrenheit.         Patient requested for half booster dose but healthcare professional (nurse) refused to give half doe due to patient medical history of cancer.  No relevant concomitant medications were reported.   This case was linked to MOD-2021-417464 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Lymphadenopathy
Clinical narrative: The muscle under armpit is swollen in injection arm; Feeling bad; Bad headache, did not do much at all; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling bad), HEADACHE (Bad headache, did not do much at all) and LYMPHADENOPATHY (The muscle under armpit is swollen in injection arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 067F21A, 058K20A and 026L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), METFORMIN and ACYCLOVIR [ACICLOVIR] for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Dec-2021, the patient experienced FEELING ABNORMAL (Feeling bad) and HEADACHE (Bad headache, did not do much at all). On 19-Dec-2021, the patient experienced LYMPHADENOPATHY (The muscle under armpit is swollen in injection arm). At the time of the report, FEELING ABNORMAL (Feeling bad), HEADACHE (Bad headache, did not do much at all) and LYMPHADENOPATHY (The muscle under armpit is swollen in injection arm) outcome was unknown.            No medical history was provided by the reporter.   The patient stated that on 18-Dec-2021, the patient was feeling bad and had a bad headache and did not do much at all. On 19-Dec-2021 morning, the muscle under armpit was swollen in injection arm.  No treatment information was provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Fatigue, Headache, Hypersensitivity, Pain in extremity
Clinical narrative: skin welt in the left side of her face; itchy in her face; bruising in her face; sore arm; rash on the left side of her face; general mild allergic reaction; headache; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (skin welt in the left side of her face), PRURITUS (itchy in her face), CONTUSION (bruising in her face), PAIN IN EXTREMITY (sore arm) and RASH (rash on the left side of her face) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high. Concomitant products included ATORVASTATIN for Blood pressure management.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced URTICARIA (skin welt in the left side of her face), PRURITUS (itchy in her face), CONTUSION (bruising in her face), PAIN IN EXTREMITY (sore arm), RASH (rash on the left side of her face), HYPERSENSITIVITY (general mild allergic reaction), HEADACHE (headache) and FATIGUE (felt tired). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of Gel on her face. On 15-Apr-2021, URTICARIA (skin welt in the left side of her face), PRURITUS (itchy in her face), CONTUSION (bruising in her face), PAIN IN EXTREMITY (sore arm), RASH (rash on the left side of her face), HYPERSENSITIVITY (general mild allergic reaction), HEADACHE (headache) and FATIGUE (felt tired) had resolved.            Patient had mild allergic reaction to the second dose which started one and a half hour after the second dose. After putting Benadryl gel on her face, symptoms were gone away after 20-30 minutes. She also had sore arm, headache and felt tired during the same day.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: skin welt in the left side of her face; itchy in her face; bruising in her face; sore arm; rash on the left side of her face; general mild allergic reaction; headache; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (skin welt in the left side of her face), PRURITUS (itchy in her face), CONTUSION (bruising in her face), PAIN IN EXTREMITY (sore arm) and RASH (rash on the left side of her face) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high. Concomitant products included ATORVASTATIN for Blood pressure management.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced URTICARIA (skin welt in the left side of her face), PRURITUS (itchy in her face), CONTUSION (bruising in her face), PAIN IN EXTREMITY (sore arm), RASH (rash on the left side of her face), HYPERSENSITIVITY (general mild allergic reaction), HEADACHE (headache) and FATIGUE (felt tired). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of Gel on her face. On 15-Apr-2021, URTICARIA (skin welt in the left side of her face), PRURITUS (itchy in her face), CONTUSION (bruising in her face), PAIN IN EXTREMITY (sore arm), RASH (rash on the left side of her face), HYPERSENSITIVITY (general mild allergic reaction), HEADACHE (headache) and FATIGUE (felt tired) had resolved.            Patient had mild allergic reaction to the second dose which started one and a half hour after the second dose. After putting Benadryl gel on her face, symptoms were gone away after 20-30 minutes. She also had sore arm, headache and felt tired during the same day.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: After 2nd shot she had a Fever 102F for 1 day; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (After 2nd shot she had a Fever 102F for 1 day) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 029L20A) for COVID-19 vaccination.     The patient's past medical history included Cancer.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (After 2nd shot she had a Fever 102F for 1 day). On 13-Feb-2021, PYREXIA (After 2nd shot she had a Fever 102F for 1 day) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, Body temperature: 102 (High) she had a Fever 102 F for 1 day.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-417433 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pain, Pyrexia
Clinical narrative: not feeling 100 percent good; pain; fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (not feeling 100 percent good), PAIN (pain) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced FEELING ABNORMAL (not feeling 100 percent good), PAIN (pain) and PYREXIA (fever). At the time of the report, FEELING ABNORMAL (not feeling 100 percent good), PAIN (pain) and PYREXIA (fever) outcome was unknown.            Agent was unable to gather more information or consent  Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: pfizer (2 pfizer vaccines) and pfizer (2 pfizer vaccines). Past adverse reactions to the above products included Pain in arm with pfizer and pfizer.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.            No concomitant medications reported by reporter No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: They put it in the incorrect injection site, they put it subcutaneous; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (They put it in the incorrect injection site, they put it subcutaneous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 18-Dec-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (They put it in the incorrect injection site, they put it subcutaneous). On 18-Dec-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (They put it in the incorrect injection site, they put it subcutaneous) had resolved.            Concomitant medication was not provided.  Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular, Rash pruritic
Clinical narrative: the rash as small red dots on the stomach and hip, and it was itchy; the rash as small red dots on the stomach and hip, and it was itchy; experienced a rash on stomach and hip/rash on right part of the abdomen and right hip; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (the rash as small red dots on the stomach and hip, and it was itchy), RASH MACULAR (the rash as small red dots on the stomach and hip, and it was itchy) and RASH (experienced a rash on stomach and hip/rash on right part of the abdomen and right hip) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 071F21A, 074M20A and 030A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Nov-2021, the patient experienced RASH PRURITIC (the rash as small red dots on the stomach and hip, and it was itchy), RASH MACULAR (the rash as small red dots on the stomach and hip, and it was itchy) and RASH (experienced a rash on stomach and hip/rash on right part of the abdomen and right hip). The patient was treated with PREDNISONE for Rash, at an unspecified dose and frequency and CORTISONE for Rash, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (the rash as small red dots on the stomach and hip, and it was itchy), RASH MACULAR (the rash as small red dots on the stomach and hip, and it was itchy) and RASH (experienced a rash on stomach and hip/rash on right part of the abdomen and right hip) had resolved.            Concomitant medication included Blood pressure pills.  The patient reported having a rash on the right side of abdomen and right hip the day after receiving the booster dose. Patient described the rash as small red dots on the stomach and hip, and it was itchy.This reaction was resolved with the treatment given by the doctor. Patient went to the urgent care room and the doctor gave a cortisone shot.   This case was linked to MOD-2021-417555, MOD-2021-417565 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Vaccination complication, Vaccination site swelling
Clinical narrative: Lot of side effects that lasted a long time after the 1st two Moderna vaccines.; Swelling at the site of injection (Left Arm); Nausea; fatigue that lasted for 4-weeks; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Lot of side effects that lasted a long time after the 1st two Moderna vaccines.), VACCINATION SITE SWELLING (Swelling at the site of injection (Left Arm)), NAUSEA (Nausea) and FATIGUE (fatigue that lasted for 4-weeks) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Lot of side effects that lasted a long time after the 1st two Moderna vaccines.), VACCINATION SITE SWELLING (Swelling at the site of injection (Left Arm)), NAUSEA (Nausea) and FATIGUE (fatigue that lasted for 4-weeks). In February 2021, FATIGUE (fatigue that lasted for 4-weeks) had resolved. At the time of the report, VACCINATION COMPLICATION (Lot of side effects that lasted a long time after the 1st two Moderna vaccines.), VACCINATION SITE SWELLING (Swelling at the site of injection (Left Arm)) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-418071 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore arm) and fatigue (tired) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 030A21A and 074M20A) for COVID-19 immunization. No medical history reported. Concurrent medical conditions included abnormal blood pressure. On Feb 2, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 4, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 4, 2021, patient experienced pain in extremity (sore arm) and fatigue (tired). At the time of the report, pain in extremity (sore arm) and fatigue (tired) outcome: unknown. Concomitant medication included blood pressure pills. No treatment medications provided. This case linked to MOD-2021-417532, MOD-2021-417565 (patient link).
Sex: U
Vaccine: COVID19
Symptoms: Blood urine present, Glomerular filtration rate, Glomerular filtration rate decreased
Clinical narrative: GFR go way down; blood in their  urine; This spontaneous case was reported by an other health care professional and describes the occurrence of GLOMERULAR FILTRATION RATE DECREASED (GFR go way down) and BLOOD URINE PRESENT (blood in their  urine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GLOMERULAR FILTRATION RATE DECREASED (GFR go way down) and BLOOD URINE PRESENT (blood in their  urine). At the time of the report, GLOMERULAR FILTRATION RATE DECREASED (GFR go way down) and BLOOD URINE PRESENT (blood in their  urine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Glomerular filtration rate: low (Low) Low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment medications provided.
Sex: U
Vaccine: COVID19
Symptoms: Axillary mass
Clinical narrative: lump in your armpit after getting the vaccine booster; This spontaneous case was reported by a nurse and describes the occurrence of AXILLARY MASS (lump in your armpit after getting the vaccine booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AXILLARY MASS (lump in your armpit after getting the vaccine booster). At the time of the report, AXILLARY MASS (lump in your armpit after getting the vaccine booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Myalgia
Clinical narrative: Felt so lousy with headache; Felt so lousy with headache; Every muscle is sore; A lot of chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt so lousy with headache), HEADACHE (Felt so lousy with headache), MYALGIA (Every muscle is sore) and CHILLS (A lot of chills) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Felt so lousy with headache), HEADACHE (Felt so lousy with headache), MYALGIA (Every muscle is sore) and CHILLS (A lot of chills). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Felt so lousy with headache), HEADACHE (Felt so lousy with headache), MYALGIA (Every muscle is sore) and CHILLS (A lot of chills) outcome was unknown.            No concomitant medications were reported.   This case was linked to MOD-2021-417593 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore arm) and fatigue (tired) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 074M20A) for COVID-19 immunization. Concurrent medical conditions included abnormal blood pressure. On Feb 2, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 2, 2021, patient experienced pain in extremity (sore arm) and  fatigue (tired). At the time of the report, pain in extremity (sore arm) and  fatigue (tired) outcome: unknown.   Concomitant medication included blood pressure pills. Treatment information unknown. This case linked to MOD-2021-417555, MOD-2021-417532 (patient link).
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Myalgia
Clinical narrative: felt so lousy with headache; every muscle is sore; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt so lousy with headache), MYALGIA (every muscle is sore), CHILLS (chills) and HEADACHE (headache) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021 at 1:45 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021 at 9:00 AM, the patient experienced FEELING ABNORMAL (felt so lousy with headache), MYALGIA (every muscle is sore), CHILLS (chills) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felt so lousy with headache), MYALGIA (every muscle is sore), CHILLS (chills) and HEADACHE (headache) outcome was unknown.            Patient experienced the same symptoms again, but with greater intensity starting around 9:00 PM No concomitant medication was reported by the reporter.   This case was linked to MOD-2021-417562 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: got moderna full dose after two sinopharm doses; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got moderna full dose after two sinopharm doses) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got moderna full dose after two sinopharm doses). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got moderna full dose after two sinopharm doses) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient received Moderna full dose after two sinopharm dose  No concomitant and treatment information were reported by the reporter
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Lymphadenopathy, Myalgia
Clinical narrative: Flu like symptoms; Swollen lymph nodes in both armpits; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), LYMPHADENOPATHY (Swollen lymph nodes in both armpits) and MYALGIA (Body aches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069821A, 0011321A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), LYMPHADENOPATHY (Swollen lymph nodes in both armpits) and MYALGIA (Body aches). The patient was treated with CHLORPHENAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (THERAFLU [CHLORPHENAMINE MALEATE;DEXTROMETHORPHAN HYDROBROMIDE;PARACETAMOL;PSEUDOEPHEDRINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and MYALGIA (Body aches) had resolved and LYMPHADENOPATHY (Swollen lymph nodes in both armpits) had not resolved.            No Concomitant product use was reported.  The patient reported that they were experiencing swollen lymph nodes in both armpits, along with body aches and flu like symptoms. At the time of call, the patient reported that only the symptoms of swollen lymph nodes were ongoing.
Age: 102.0
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: slightly sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (slightly sick) in a 102-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced ILLNESS (slightly sick). At the time of the report, ILLNESS (slightly sick) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication information was not provided. Treatment information was not provided.   This case was linked to MOD-2021-417671, MOD-2021-417678 (Patient Link).
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported.  Reporter stated that the vaccines had remained in their freezer at -24 degree Fahrenheit up until the day of the vaccine administration, then added each vial to refrigerator as needed. The temp of the refrigerator was 4 degree Celsius.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Illness, Pain, Pyrexia
Clinical narrative: Felt sick; Felt like her uterus and other internal organs on were on fire; Had body aches; Fever; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (Felt sick), BURNING SENSATION (Felt like her uterus and other internal organs on were on fire), PAIN (Had body aches) and PYREXIA (Fever) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced ILLNESS (Felt sick), BURNING SENSATION (Felt like her uterus and other internal organs on were on fire), PAIN (Had body aches) and PYREXIA (Fever). In 2021, ILLNESS (Felt sick), BURNING SENSATION (Felt like her uterus and other internal organs on were on fire), PAIN (Had body aches) and PYREXIA (Fever) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient was in contact with ophthalmologists.  The patient took no concomitant medications and no medications to alleviate the symptoms.   This case was linked to MOD-2021-417751, MOD-2021-417772 (Patient Link).
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Headache, Pyrexia, Vomiting
Clinical narrative: pain in the right side of the stomach; got headache; vomiting; high temperature; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (pain in the right side of the stomach), HEADACHE (got headache), VOMITING (vomiting) and PYREXIA (high temperature) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Dec-2021, the patient experienced ABDOMINAL PAIN UPPER (pain in the right side of the stomach), HEADACHE (got headache), VOMITING (vomiting) and PYREXIA (high temperature). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (pain in the right side of the stomach), HEADACHE (got headache), VOMITING (vomiting) and PYREXIA (high temperature) outcome was unknown.            Concomitant product use was not provided by the reporter.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired vaccine) in a 37-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021 at 3:49 AM, the patient received second dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) .5 milliliter. On 17-Dec-2021 at 3:49 AM,  after starting mRNA-1273 (COVID 19 Vaccine Moderna), the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired vaccine). On 17-Dec-2021 at 3:49 AM, EXPIRED PRODUCT ADMINISTERED (received expired vaccine) had resolved.        For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was provided. No treatment medication details was provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Follow up document received included E-mail ID confirmed and document contains Non-significant information.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired vaccine) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired vaccine). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Non-significant follow up updated reporter details
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021 at 3:40 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Follow up received includes reporter details
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired vaccine) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021 at 3:49 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 17-Dec-2021 at 3:49 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired vaccine). On 17-Dec-2021 at 3:49 AM, EXPIRED PRODUCT ADMINISTERED (received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was provided. No treatment medication details was provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Non-significant Follow up E-mail ID confirmed
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired vaccine) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C21A and Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired vaccine). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drug information was provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Follow up document received included Follow up-E-mail ID confirmed and the document contains Non-significant information
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021 at 3:49 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 17-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment drugs were reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Non-significant follow-up received includes reporters address updated and email address confirmed.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021 at 3:49 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Non significant follow up received includes reporters address updated and email address confirmed.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021 at 3:49 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 17-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information were reported.    Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Non significant follow up received includes reporters address updated and email address confirmed.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case reported by a nurse, describes the occurrence of administered expired product (received expired vaccine) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 026C21A) for COVID-19 immunization. No medical history reported. On Dec 17, 2021, at 3:40 pm, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; .5mL. On Dec 17, 2021, patient administered expired product (received expired vaccine). On Dec 17, 2021, administered expired product (received expired vaccine) resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information. Most recent follow-up information incorporated: On Dec 17, 2021: follow-up received included reporter's updated address and confirmed email address.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021 at 3:49 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 17-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Non-significant follow-up received includes reporters address updated and email address confirmed.